Company Filing History:
Years Active: 2021
Title: Innovations by Ko-Chiang Chen in Neurodegenerative Disorder Treatment
Introduction
Ko-Chiang Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in developing formulations for treating neurodegenerative disorders. His innovative approach combines both sustained-release and immediate-release drugs to enhance therapeutic efficacy.
Latest Patents
Ko-Chiang Chen holds a patent for an oral pH independent dosage formulation aimed at treating neurodegenerative disorders. This formulation is characterized by its unique ability to maintain a pH-independent dissolution profile of memantine across a pH range from about 1.0 to about 7.0. The formulation includes memantine as the sustained-release drug and donepezil and/or memantine as the immediate-release component.
Career Highlights
Chen is associated with Center Laboratories, Inc., where he continues to work on innovative pharmaceutical solutions. His research focuses on improving drug delivery systems to better address the needs of patients suffering from neurodegenerative conditions.
Collaborations
Some of his notable coworkers include Meng-Ju Lee and Shu-Hsien Chang, who contribute to the collaborative efforts in research and development at Center Laboratories, Inc.
Conclusion
Ko-Chiang Chen's work exemplifies the intersection of innovation and healthcare, particularly in the treatment of neurodegenerative disorders. His contributions are paving the way for more effective therapeutic options in this critical area of medicine.